Share on LinkedInShare on LinkedIn

ARTICLE · 03 AUGUST 2010

Court of Appeal Accepts GlaxoSmithKline Arguments in Transfer Pricing Case

Borden Ladner Gervais LLP
Borden Ladner Gervais LLP
Contributor
Borden Ladner Gervais LLP

Borden Ladner Gervais LLP

With over 750 lawyers, intellectual property agents and other professionals, BLG services...

View firm profile
Explore more from Borden Ladner Gervais LLP

On July 26, 2010, the Canadian Federal Court of Appeal released its decision in the case of "GlaxoSmithKline Inc. v. Her Majesty The Queen".

CanadaTax

On July 26, 2010, the Canadian Federal Court of Appeal released its decision in the case of GlaxoSmithKline Inc. v. Her Majesty The Queen. The case was heard on March 10, 2010 at the instance of the taxpayer on appeal from a decision of the Tax Court of Canada (2008 TCC 324), which, except for a minor upward adjustment to pricing, upheld the Minister of National Revenue's assessment against the taxpayer.

The Federal Court of Appeal found in favour of the taxpayer, that the Tax Court Judge had erred in failing to apply the proper test for purposes of Canada's transfer pricing rules. The Court, however, did not make any finding as to the proper transfer price but instead referred the matter back to the lower court for rehearing and reconsideration in light of its Reasons.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from